Effect of moxonidine on left ventricular hypertrophy in hypertensive patients

Haczynski J et al.

Effect of moxonidine on left ventricular hypertrophy in hypertensive patients

Journal of Clinical and Basic Cardiology 2001; 4 (1): 61-65

PDF Summary Figures

Figure

Maximize View	Moxonidin - enddiastolischer Durchmesser Figure 1: Interventricular septum end-diastolic diameter (IVS EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 months (visit 7) moxonidine monotherapy. Keywords: Diagramm, end-diastolic diameter, Enddiastolischer Durchmesser, interventricular septum, Interventrikuläres Septum, Moxonidin, moxonidine


Maximize View	Moxonidin - enddiastolischer Durchmesser Figure 2: Left ventricular posterior wall end-diastolic diameter (PW EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy Keywords: Diagramm, end-diastolic diameter, Enddiastolischer Durchmesser, left ventricular posterior wall, linksventrikuläre Hinterwand, Moxonidin, moxonidine


Maximize View	Moxonidin - enddiastolischer Durchmesser Figure 3: Left ventricular end-diastolic diameter (LV EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy. Keywords: Diagramm, left ventricular end-diastolid diameter, linksventrikulärer enddiastolischer Durchmesser, Moxonidin, moxonidine


Maximize View	Moxonidin - linksventrikuläre Masse Figure 4: Left ventricular (LV) mass at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy. Keywords: Diagramm, left ventricular mass, linksventrikuläre Masse, Moxonidin, moxonidine